In conclusion, this study shows that PAR-2 expression is increased on inflammatory monocytes in two groups of patients with asthma; PAR-2 expression on inflammatory monocytes is increased in subjects with severe asthma and in subjects that have experienced asthma exacerbations over the last year irrespective of disease severity. This evidence concerns the gene F2RL1 and asthma.